Related Experiment Video
Updated: Apr 14, 2026
07:21
Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor
Published on: May 2, 2022
2.7K
Immune Therapy in GI Malignancies: A Review
Judy Wang1, Kim A Reiss1, Rina Khatri1
1All authors: Skip Viragh Center for Pancreatic Cancer Research and Clinical Care, Sidney Kimmel Cancer Center at The Johns Hopkins University, Baltimore, MD.
Summary
Understanding the immune system
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Tumor immune evasion is determined by the balance between pro-tumor and anti-tumor immune responses.
- Complex interactions between tumors, their microenvironment, and the immune system are key to developing effective cancer immunotherapies.
- Cancer-associated inflammation and immune suppression create challenges for effective anti-cancer immunity.
Purpose of the Study:
- To review the role of oncogenes in cancer-associated inflammation.
- To explore factors contributing to local and systemic immune suppression in cancer.
- To discuss immunotherapy strategies for overcoming tumor immune privilege.
Main Methods:
- Literature review of oncogene-induced inflammation.
- Analysis of local and systemic factors in cancer immune suppression.
- Review of current and emerging immunotherapy approaches.
Main Results:
- Oncogenes can drive inflammation that promotes tumor growth.
- Tumor microenvironment and systemic factors often create immunosuppressive conditions.
- Immunotherapies aim to reverse immune suppression and overcome tumor defenses.
Conclusions:
- Modulating the immune response is crucial for cancer control.
- Targeting oncogenes and immunosuppressive factors can enhance immunotherapy efficacy.
- Overcoming immune privilege is essential for successful cancer treatment.
More Related Videos
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
22.2K
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.6K
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
986
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
986
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
716
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
716
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
802
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
802
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
782
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
782